Authors: Perrin, MH Fischer, WH Kunitake, KS Craig, AG Koerber, SC Cervini, LA Rivier, JE Groppe, JC Greenwald, J Nielsen, SM Vale, WW

Citation: Mh. Perrin et al., Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factorreceptor, J BIOL CHEM, 276(34), 2001, pp. 31528-31534

Authors: Erhardt, NM Fradinger, EA Cervini, LA Rivier, JE Sherwood, NM

Citation: Nm. Erhardt et al., Early expression of pituitary adenylate cyclase-activating polypeptide andactivation of its receptor in chick neuroblasts, ENDOCRINOL, 142(4), 2001, pp. 1616-1625

Authors: Rivier, JE Struthers, RS Porter, J Lahrichi, SL Jiang, GC Cervini, LA Ibea, M Kirby, DA Koerber, SC Rivier, CL

Citation: Je. Rivier et al., Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH)antagonists, J MED CHEM, 43(5), 2000, pp. 784-796

Authors: Rivier, JE Porter, J Cervini, LA Lahrichi, SL Kirby, DA Struthers, RS Koerber, SC Rivier, CL

Citation: Je. Rivier et al., Design of monocyclic (1-3) and dicyclic (1-3/4-10) gonadotropin releasing hormone (GnRH) antagonists, J MED CHEM, 43(5), 2000, pp. 797-806

Authors: Rivier, JE Jiang, GC Struthers, RS Koerber, SC Porter, J Cervini, LA Kirby, DA Craig, AG Rivier, CL

Citation: Je. Rivier et al., Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH)antagonists, J MED CHEM, 43(5), 2000, pp. 807-818

Authors: Perrin, MH Sutton, SW Cervini, LA Rivier, JE Vale, WW

Citation: Mh. Perrin et al., Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors, J PHARM EXP, 288(2), 1999, pp. 729-734